Estrone potentiates myeloid cell differentiation: A role for 17β- hydroxysteroid dehydrogenase in modulating hemopoiesis

Experimental Hematology

Volumn 27, Issue 3, 1999, Pages 451-460

  Mountford, Joanne C ^a   Bunce, Christopher M ^b   Hughes, Susan V ^a   Drayson, Mark T ^a,b   Webb, David ^a   Brown, Geoffery ^a,b   Hewison, Martin ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Leukaemia Res Fund D   (United Kingdom)

Author keywords

1 ,25 Dihydroxy vitamin D3; 17 Hydroxysteroid dehydrogenase; All trans retinoic acid; Estrogen metabolism; Myelopoiesis

Indexed keywords

COLECALCIFEROL; ESTRONE; RETINOIC ACID; TESTOSTERONE 17BETA DEHYDROGENASE;

ARTICLE; CELL FATE; CELL SPECIFICITY; ESTROGEN METABOLISM; GROWTH REGULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; MYELOPOIESIS; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMYELOCYTE; RECEPTOR DENSITY;

17-HYDROXYSTEROID DEHYDROGENASES; AROMATASE; CELL DIFFERENTIATION; CHOLECALCIFEROL; ENZYME INDUCTION; ESTRADIOL; ESTRONE; FETAL BLOOD; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, LEUKEMIC; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HL-60 CELLS; HUMANS; MONOCYTES; NEOPLASM PROTEINS; NEUTROPHILS; PROTEIN ISOFORMS; RECEPTORS, ESTROGEN; RNA, MESSENGER; RNA, NEOPLASM; TRETINOIN;

EID: 0033045005     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(98)00078-2     Document Type: Article

References (31)

1. Charlton B.G., Taylor P.R.A., Proctor S.J. The PACE (population-adjusted clinical epidemiology) stategy. a new approach to multi-centred clinical research Q J Med. 90:1997;147.
2. Breitman T.R., Selonick S.E., Collins S.J. Induction of differentiation of the human promyelocytic leukaemic cell line HL60 by retinoic acid. Proc Natl Acad Sci U S A. 77:1980;2936.
3. 3 inhibits proliferation of human promyelocytic leukemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal bone marrow cells. Leukemia Res. 7:1983;51.
4. 3 and its fluorinated analogues. Cancer Res. 44:1984;5624.
5. Breitman T.R., Collins S.J., Keene B.R. Terminal differentiation of human promyelocytic leukaemic cells in primary culture in response to retinoic acid. Blood. 57:1981;1000.
6. Warrell R.P. Jr., Maslak P., Eardley A., Heller G., Miller W.H., Frankel S.R. Treatment of acute promyelocytic leukemia with all-trans retinoic acid - an update of the New York experience. Leukemia. 8:1994;S33.
7. Chomiene C., Fenaux P., Degos L. Retinoid differentiation therapy in promyelocytic leukemia. FASEB J. 10:1996;1025.
8. Besa E.C., Abraham J.L., Bartholomew M.J., Hyzinski M., Nowell P.C. Treatment with 13-cis-retinoic acid in transfusion dependent patients with myelodysplastic syndrome and decreased toxicity with addition of alpha-tocopherol. Am J Med. 89:1990;739.
9. Warrell P.P., Frankel S.R., Miller W.H., Scheinberg D.A., Itri L.M., Hittelman W.N., Vyas R., Andreef M., Tafuri A., Jakubowski A., Gordon M.S., Dmitrovsky E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N Engl J Med. 324:1991;1385.
10. Ohno R., Naoe T., Hirano M., Kabayashi M., Hirai H., Tubaki K., Oh K. Treatment of myelodysplastic syndromes with all-trans retinoic acid. Blood. 81:1993;1152.
11. Bouillon R., Okamura W.H., Norman A.W. Structure function relationships in the vitamin D endocrine system. Endocr Rev. 16:1995;200.
12. Beato M., Chavez S., Truss M. Transcriptional regulation by steroid hormones. Steroids. 61:1996;240.
13. Truss M., Beato M. Steroid hormone receptors. interaction with deoxyribonucleic acid and transcription factors Endocr Rev. 14:1993;459.
14. Bunce C.M., Mountford J.C., French P.J., Mole D.J., Durham J., Michell R.H., Brown G. Potentiation of myeloid differentiation by anti-inflammatory agents, by steroids and by retinoic acid involves a single intracellular target, probably an enzyme of the aldoketoreductase family. Biochim Biophys Acta. 1311:1996;89.
15. Bunce C.M., Brown G., Hewison M. Vitamin D and haematopoiesis. Trends Endocrinol Metab. 8:1997;245.
16. Adamski J., Normand T., Leenders F., Monte D., Begue A., Stehelin D., Jungblut P.W., de Launoit Y. Molecular cloning of a novel widely expressed human 80KDa 17β-hydroxysteroid dehydrogenase IV. Biochem J. 311:1995;437.
17. 3 results indifferentiation towards neutrophils or monocytes or a failure to differentiate and apoptosis. Leukemia. 9:1995;410.
18. 3 regulates estrogen metabolism in cultured keratinocytes. Endocrinology. 138:1997;3711.
19. Labrie F. Intracrinology - at the cutting edge. Mol Cell Endocrinol. 78:1991;C113.
20. Torchia J., Rose D.W., Inostroza J., Kamei Y., Westin S., Glass C.K., Rosenfeld M.G. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature. 387:1997;677.
21. Garland J.M., Dexter T.M. 20-α-hydroxysteroid dehydrogenase expression in hematopoietic cell cultures and its relationship to interleukin-3. Eur J Immunol. 12:1982;998.
22. Jilka R.L., Passeri G., Girasole G., Cooper S., Abrams J., Broxmyer H., Manolagas S.C. Estrogen loss upregulates hematopoeisis in the mouse. a mediating role of IL-6 Exp Hematol. 23:1995;500.
23. Jacob F., Homann D., Adamski J. Expression and regulation of aromatase and 17β-hydroxysteroid dehydrogenase type 4 in human THP1 leukaemia cells. J Steroid Biochem Mol Biol. 55:1995;555.
24. Peltoketo H., Isomaa V., Poutanen M., Vihko R. Expression and regulation of 17β-hydroxysteroid dehydrogenase type 1. J Endocrinol. 150:1996;S21.
25. Luu-The V., Zhang Y., Poirere D., Labrie F. Characteristics of human types 1, 2 and 3 17β-hydroxysteroid dehydrogenase activities. oxidation/reduction and inhibition J Steroid Biochem Mol Biol. 55:1995;581.
26. Reed M.J., Rea D., Duncan L.J., Parker M.G. Regulation of estradiol 17β-hydroxysteroid dehydrogenase expression and activity by retinoic acid in T47D breast cancer cells. Endocrinology. 135:1994;4.
27. Jakob F., Tony H.P., Schneider D., Thole H.H. Immunological detection of the oestradiol receptor protein in cell lines derived from the lymphatic system and the haematopoietic system. Variability of specific hormone binding in vitro. J Endocrinol. 134:1992;397.
28. Larocca L.M., Piantelli M., Leone G., Sica S., Teofili L., Panici P.B., Acambia G., Mancuso S., Capelliand A., Ranelletti F.O. Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias. growth inhibitory effect of oestrogen and flavonoids Br J Haematol. 75:1990;489.
29. Kuiper G.G.J.M., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., Gustafsson J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β Endocrinology. 138:1997;865.
30. Morley P., Whitfield J.F., Vanderhyden B.C., Tsang B.K., Schwartz J.L. A new, nongenomic estrogen action. the rapid release of intracellular calcium Endocrinology. 131:1992;1305.
31. Simpson E.R., Mahendroo M.S., Means G.D., Kilgore M.W., Hinshelwood M.M., Grahamlorence S., Amarneh B., Ito Y.J., Fisher C.R., Michael M.D., Mendelson C.R., Bulun S.E. Aromatase cytochrome-P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev. 15:1994;342.